Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Boehringer Ingelheim
Baxter
Mallinckrodt
Merck

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Ibodutant


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Ibodutant?

Ibodutant is an investigational drug.

There have been 5 clinical trials for Ibodutant. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2014.

The most common disease conditions in clinical trials are Syndrome, Irritable Bowel Syndrome, and Diarrhea. The leading clinical trial sponsors are Menarini Group and [disabled in preview].

There are fourteen US patents protecting this investigational drug and two hundred and fourteen international patents.

Recent Clinical Trials for Ibodutant
TitleSponsorPhase
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)Menarini GroupPhase 3
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)Menarini GroupPhase 3
52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)Menarini GroupPhase 3

See all Ibodutant clinical trials

Clinical Trial Summary for Ibodutant

Top disease conditions for Ibodutant
Top clinical trial sponsors for Ibodutant

See all Ibodutant clinical trials

US Patents for Ibodutant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ibodutant ⤷  Sign up for a Free Trial Compositions and methods for inducing urinary voiding and defecation Dignify Therapeutics, LLC (Research Triangle Park, NC) ⤷  Sign up for a Free Trial
Ibodutant ⤷  Sign up for a Free Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Sign up for a Free Trial
Ibodutant ⤷  Sign up for a Free Trial Class of mu-opioid receptor agonists THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, NY) ⤷  Sign up for a Free Trial
Ibodutant ⤷  Sign up for a Free Trial Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Sign up for a Free Trial
Ibodutant ⤷  Sign up for a Free Trial Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) ⤷  Sign up for a Free Trial
Ibodutant ⤷  Sign up for a Free Trial Compositions and methods for treating or preventing gut permeability-related disorders Gelesis LLC (Boston, MA) ⤷  Sign up for a Free Trial
Ibodutant ⤷  Sign up for a Free Trial Linear basic compounds having NK-2 antagonist activity and formulations thereof Menarini Ricerche S.P.A. (Pomezia, IT) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ibodutant

Drugname Country Document Number Estimated Expiration Related US Patent
Ibodutant Canada CA2918245 2033-08-01 ⤷  Sign up for a Free Trial
Ibodutant European Patent Office EP3027199 2033-08-01 ⤷  Sign up for a Free Trial
Ibodutant Japan JP2016527271 2033-08-01 ⤷  Sign up for a Free Trial
Ibodutant Japan JP6570521 2033-08-01 ⤷  Sign up for a Free Trial
Ibodutant World Intellectual Property Organization (WIPO) WO2015017575 2033-08-01 ⤷  Sign up for a Free Trial
Ibodutant Australia AU2017261372 2036-05-05 ⤷  Sign up for a Free Trial
Ibodutant Canada CA3023278 2036-05-05 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Boehringer Ingelheim
Baxter
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.